WHO approves Ebola test reagent developed by Chinese firm

Image
Press Trust of India Beijing
Last Updated : May 01 2015 | 7:57 PM IST
An Ebola test reagent developed by a Chinese firm has been approved by the WHO, the third diagnostic kit approved by the world health body after those manufactured by American and German firms.
Manufactured by Shanghai ZJ Bio-Tech Co Ltd, the real-time diagnostic kit has been listed as eligible for WHO procurement and recommended to be used to diagnose Ebola virus disease worldwide, the company said in a statement.
A total of only tree kits have been approved by the World Health Organisation so far. The two others were manufactured by developers in the US and Germany, state-run Xinhua news agency reported.
Last November, the China Food and Drug Administration had approved the test reagent.
Shanghai ZJ Bio-Tech Co Ltd is a high-tech enterprise which focuses on developing, manufacturing and selling gene diagnostic reagents.
Around 26,300 people have so far been infected with the virus, and nearly 10,900 of them have died.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 01 2015 | 7:57 PM IST

Next Story